Zero Nonconformities in Quality Management for Patient Support Programs
In the highly specialized and strictly regulated fields of pharmaceutical management and patient support services, a robust Quality Management System (QMS) serves as the cornerstone of service credibility and represents a concrete commitment to patient safety and data privacy. PatientsForce Group (Tsai-Hung Health Integrated Group), a long-standing leader in this domain, is proud to announce that its two core subsidiaries—Care Strategy Consulting Co., Ltd. and Care BioMedical Technology Co., Ltd.—have once again successfully renewed their SGS ISO 9001 Quality Management System certification.
This achievement not only underscores the Group’s unwavering commitment to quality excellence, but also lays a forward-looking foundation for its digital transformation and sustainability initiatives heading into 2026.
Eight Years of Uninterrupted Quality Commitment: QMS Safeguarding the Patient Journey
This ISO 9001 renewal marks the continuation of a long-term quality commitment that began with the Group’s initial certification in 2018. The scope of certification simultaneously covers both Care Strategy and Care BioMedical, demonstrating the successful integration of a unified, high-standard management framework across the Group’s service ecosystem.
For patient support programs, a mature and stable QMS is mission-critical:
- Enhanced Compliance and Transparency
Through standardized, traceable, and measurable operational processes, the Group ensures that patient assistance and support services—including PSPs, PAPs, medication safety programs, and disease management—meet the highest regulatory and ethical standards, while significantly improving service transparency. - Operational Stability and Sustainable Evolution
Since 2018, the continuous application of the PDCA (Plan–Do–Check–Act) cycle has enabled the Group to maintain operational resilience amid the rapidly evolving biomedical landscape, positioning it as a long-term, trusted Patient Solution Partner for international pharmaceutical companies and healthcare systems. - A Cornerstone of ESG Governance
PatientsForce regards ISO 9001 as a foundational pillar of “Governance” within its Environmental, Social, and Governance (ESG) framework, clearly demonstrating its responsibility and commitment to sustainable development.
Proactive Readiness for 2026: Integrating AI Ethics and ESG into Risk Governance
Notably, in anticipation of the upcoming ISO 9001 standard revision scheduled for release in 2026, the Group has already taken proactive steps to incorporate emerging risks into its governance structure as a key supply-chain partner. These initiatives include:
- AI Application Governance and Risk Assessment
Emphasizing data ethics, model reliability, and the protection of patient privacy and information security. - Environmental and Climate Risk Assessment
In response to ESG and sustainability trends, environmental responsibility has been embedded into service processes. The Group has also obtained an EcoVadis medal and committed to SBTi net-zero targets, further reinforcing its sustainability credentials.
Through the collective efforts of the management team and compliance center, the Group successfully renewed its SGS ISO 9001 certification once again in 2025. However, quality certification is not an endpoint—it is a milestone within an ongoing and effective PDCA cycle.
Looking ahead, the PatientsForce brand will continue to optimize every critical touchpoint along the patient journey, from pre-launch Early Access Programs (EAP) to post-launch PAP/PSP services. By transforming “compliance” into demonstrable value, PatientsForce is committed to building a safer, smarter, and more sustainable future for patients and healthcare systems alike.
